Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Integrated BioTherapeutics, Inc. Snapshot 5 Integrated BioTherapeutics, Inc. Overview 5 Key Information 5 Key Facts 5 Integrated BioTherapeutics, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Integrated BioTherapeutics, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Combination Treatment Modalities 10 Integrated BioTherapeutics, Inc. - Pipeline Products Glance 11 Integrated BioTherapeutics, Inc. - Clinical Stage Pipeline Products 11 Phase I Products/Combination Treatment Modalities 11 Integrated BioTherapeutics, Inc. - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Discovery Products/Combination Treatment Modalities 13 Integrated BioTherapeutics, Inc. - Drug Profiles 14 STEBVax 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 (Ebola + Marburg) vaccine 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Antibodies for Ebola and Marburg Viral Infections 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 AT-62aa 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Monoclonal Antibodies for Ebola and Marburg Infections 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Monoclonal Antibodies for Equine Encephalitis and Chikungunya 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Monoclonal Antibodies to Inhibit E2 Glycoprotein for HCV 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Monoclonal Antibody 1 for Staphylococcus Aureus Infections 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Integrated BioTherapeutics, Inc. - Pipeline Analysis 26 Integrated BioTherapeutics, Inc. - Pipeline Products by Target 26 Integrated BioTherapeutics, Inc. - Pipeline Products by Route of Administration 27 Integrated BioTherapeutics, Inc. - Pipeline Products by Molecule Type 28 Integrated BioTherapeutics, Inc. - Pipeline Products by Mechanism of Action 29 Integrated BioTherapeutics, Inc. - Recent Pipeline Updates 30 Integrated BioTherapeutics, Inc. - Dormant Projects 31 Integrated BioTherapeutics, Inc. - Locations And Subsidiaries 32 Head Office 32 Appendix 33 Methodology 33 Coverage 33 Secondary Research 33 Primary Research 33 Expert Panel Validation 33 Contact Us 33 Disclaimer 34

List of Tables Integrated BioTherapeutics, Inc., Key Information 5 Integrated BioTherapeutics, Inc., Key Facts 5 Integrated BioTherapeutics, Inc. - Pipeline by Indication, 2016 7 Integrated BioTherapeutics, Inc. - Pipeline by Stage of Development, 2016 8 Integrated BioTherapeutics, Inc. - Monotherapy Products in Pipeline, 2016 9 Integrated BioTherapeutics, Inc. - Combination Treatment Modalities in Pipeline, 2016 10 Integrated BioTherapeutics, Inc. - Phase I, 2016 11 Integrated BioTherapeutics, Inc. - Preclinical, 2016 12 Integrated BioTherapeutics, Inc. - Discovery, 2016 13 Integrated BioTherapeutics, Inc. - Pipeline by Target, 2016 26 Integrated BioTherapeutics, Inc. - Pipeline by Route of Administration, 2016 27 Integrated BioTherapeutics, Inc. - Pipeline by Molecule Type, 2016 28 Integrated BioTherapeutics, Inc. - Pipeline Products by Mechanism of Action, 2016 29 Integrated BioTherapeutics, Inc. - Recent Pipeline Updates, 2016 30 Integrated BioTherapeutics, Inc. - Dormant Developmental Projects,2016 31 List of Figures Integrated BioTherapeutics, Inc. - Pipeline by Indication, 2016 7 Integrated BioTherapeutics, Inc. - Pipeline by Stage of Development, 2016 8 Integrated BioTherapeutics, Inc. - Monotherapy Products in Pipeline, 2016 9 Integrated BioTherapeutics, Inc. - Pipeline by Target, 2016 26 Integrated BioTherapeutics, Inc. - Pipeline by Molecule Type, 2016 28